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Abstract 
 
Purpose of review: In recent years, the food addiction hypothesis of loss-of-control eating has 
gained traction in the field of eating disorders. In particular, the neural process of food addiction 
plays a dominant role in the recently formulated “addictive appetite” model of bulimia nervosa 
and binge eating disorder. Nonetheless, several components of the food addiction hypothesis, 
including the presence of withdrawal and tolerance effects, as well as the proposition that some 
foods possess “addicting” properties, remain highly controversial. In response, the current 
review synthesises existing evidence for withdrawal and tolerance effects in people with 
bulimia nervosa.  
Recent findings: The recent development of a validated tool to measure withdrawal from highly 
processed foods will aid in measuring withdrawal symptoms and testing hypotheses related to 
withdrawal in the context of food addiction. We subsequently describe preclinical and human 
evidence for a central insulin- and dopamine-mediated pathway by which recurrent loss-of-
control binge eating is maintained in bulimia nervosa.  
Summary: Evidence in populations with bulimia nervosa and loss-of-control eating provides 
preliminary support for the role of food addiction in the maintenance of bulimia nervosa. Future 
longitudinal research is needed to develop a clearer profile of illness progression and to clarify 
the extent to which dysregulation in glucose metabolism contributes to food craving and 
symptom maintenance in bulimia nervosa.  
Keywords: Food addiction; bulimia nervosa; eating disorders; sugar; dopamine  
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 Background 
The concept of “food addiction” has received increasing attention in the scientific 
literature of recent years. While cogent arguments have been made against the establishment 
of food addiction as a psychiatric diagnosis in its own right [1], there is substantial evidence to 
suggest that processes similar to those observed in substance abuse disorders play a significant 
role in the maintenance of eating disorders in which loss of control of  eating is a feature (e.g., 
anorexia nervosa -binge purge type, bulimia nervosa and binge eating disorder) [2]. In this 
article, we will use bulimia nervosa (BN) as the exemplar. The “Addictive Appetite Model” 
proposes that three primary processes maintain psychopathology in BN: 1) The high salience 
of palatable foods [3], which is moderated by a genetic susceptibility to food approach 
tendencies, reduced efficiency in satiation processes [4], and/or episodes of food restriction; 2) 
Chronic stress and interpersonal difficulties resulting  in a deficiency of alternative  rewards 
and a primed stress system [5]; and 3) Large swings in blood glucose, caused  by the 
consumption of foods with a high glycaemic index, self-induced vomiting or insulin resistance 
(and insulin omission in diabetes mellitus). These pathways may contribute to compulsive 
binge eating behaviour through aberrations in dopaminergic function in a similar way to 
substance addictions.  
The current review presents a synthesis of the literature investigating some of the 
controversial aspects of applying the food addiction paradigm to eating disorders.  For instance, 
there is uncertainty as to whether tolerance and withdrawal criteria for an addictive disorder as 
specified within the DSM-5 are met. We also present a synthesis of molecular, preclinical, 
clinical, and neuroimaging evidence illustrating how fluxes in glucose and insulin moderate 
central dopaminergic functioning. 
Does Bulimia Nervosa Meet DSM-5 Criteria for an Addictive Disorder? 
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The DSM-5 criteria for an addictive disorder are presented in Table 1. The extent to 
which BN meets these criteria has been reviewed extensively elsewhere [6]. In his 2014 review, 
Brewerton acknowledges significant phenotypic overlap between disorders of substance 
dependence and BN but highlights a paucity of systematic clinical evidence for tolerance and 
withdrawal in the latter, a point frequently cited as a major weakness of the food addiction 
hypothesis [7]. Much research on tolerance and withdrawal symptoms in humans to date has 
been largely anecdotal [8]. However, herein we synthesise the evidence from new assessment 
methods.   
Tolerance 
The most compelling evidence for food tolerance is demonstrated in animal models, as 
previously reviewed by Murray, et al. [9]. Rats who voluntarily overeat highly palatable food 
exhibit evidence of a neural reward deficit due to downregulated dopamine D2 receptors, which 
worsens as weight is gained [10-12]. This decreased sensitivity to reward is directly linked to 
the onset of compulsive food seeking in rats [11]. Repetitive bingeing on sucrose interspersed 
with periods of dietary restriction causes rats to triple their overall daily sugar consumption 
[13], a finding which may be of particular importance to BN as it is characterised by 
intermittent fasting and binge episodes [14]. A similar downregulation of dopamine D2 
receptors is found in humans addicted to drugs of abuse [15] and is thought to be a key driver 
of compensatory overconsumption in the Reward Hyposensitivity Theory [16, 17]. 
Behavioural observations in people with substance use disorders mirror these findings.  
Individuals with BN endorse higher levels of  tolerance-like symptoms measured using 
the Yale Food Addiction Scale (YFAS) [8], compared with healthy controls [18, 19]. There are 
clinical reports of subthreshold BN patients initiating larger and more frequent binge episodes 
over time [20]. Consistent with these accounts is cross-sectional evidence of the correlation 
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between higher body weight and frequency and severity of binge eating episodes [21]. 
Individuals with binge-type eating disorders endorse significantly greater levels of eating for 
purposes of reward enhancement compared with weight-matched controls [22]. Such evidence, 
although compelling, remains indirect and is insufficient to prove the existence of tolerance in 
humans.  
A preference for intensely sweet food and larger quantities of sweeteners in individuals 
with BN is a characteristic often presented as an indicator of tolerance [3, 23-25]. Furthermore 
this  preference remains after ingesting a glucose load [26]. Magnetic resonance imaging (MRI) 
studies indicate hypofunctioning of gustatory and limbic circuitry in BN patients when tasting 
palatable food compared with controls [27, 28] and compared with individuals recovered from 
BN [29, 30]. This evidence is consistent with the idea that individuals with BN ingest more 
food over time because of a decreased sensitivity to sweet taste resulting from repeated binging 
on hyperpalatable foods [27].  
The development of impaired satiety mechanisms may be an indirect indicator of 
tolerance [6, 31, 32]. For example, a recent functional MRI (fMRI) study found that women in 
remission from BN exhibited the same response to taste stimuli in brain regions implicated in 
translating sensory information about taste into motivated behaviour, regardless of whether the 
individuals were hungry or sated, whilst healthy controls showed an increased response to taste 
stimuli when hungry versus when fed [33]. The authors also found an increased amygdala 
response in their remitted BN sample when fed compared to healthy controls, which they 
propose might project to the hypothalamus and motivate eating in the absence of hunger [33, 
34]. It is possible that brain circuitry in BN fails to de-value food reward when in a fed state, 
leading to eating beyond metabolic need. 
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Five years on from Brewerton’s 2014 review, there remains a paucity of direct evidence 
of tolerance in humans in relation to food intake and prospective, longitudinal studies are 
needed.  
Withdrawal Syndromes  
Preliminary evidence for a withdrawal syndrome in relationship to palatable food comes 
from animal models. There are consistent observations of strong physical (e.g., forepaw tremor, 
teeth chattering) and psychological (e.g., aggression, anxiety) withdrawal responses in rats 
during periods of withdrawal from sucrose [35-37]. The same observations, however, are not 
found with removal of high-fat foods [38] and have not yet been studied with removal of highly 
processed foods [39]. Neuroimaging studies show patterns consistent with this behavioural 
data. Sugar-dependent rats show a significant increase in extracellular acetylcholine and a 
decrease in dopamine release in the nucleus accumbens shell, as compared to control groups, 
during a 36-hour period of food deprivation [35], effects which are similar to withdrawal from 
morphine, nicotine, and alcohol. 
Traditionally withdrawal symptoms have not been clearly defined in the context of 
addictive-like eating, prompting criticism of the food addiction framework [40]. To date, the 
food addiction field has largely relied on observational and anecdotal clinical reports based on 
small cohorts or single case studies [41-46] and on self-reported endorsement of withdrawal 
symptoms on the YFAS [18] and other withdrawal scales [47]. Cross-sectional self-report 
accounts are consistent in describing physiological symptoms of withdrawal similar to those 
experienced during opiate withdrawal [8, 48]. Headaches, irritability and flu-like symptoms 
are reported by individuals abstaining from sugar [42], stomach pains, muscle spasms and 
shakiness by individuals abstaining or reducing intake of carbohydrates [43, 45], and nausea 
by individuals abstaining from salted food [49]. Furthermore, tiredness and irritability have 
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been cited as motivating factors for eating [45], providing some suggestion of food being used 
as a “pick-me-up”, or to avoid an experience of negative feelings of withdrawal.  
Symptoms of psychological withdrawal are also widely reported. Cross-sectional self-
report accounts from patients with BN reveal that most feel tension, loneliness, and physical 
symptoms of anxiety before a binge, and the majority feel that their negative psychological 
states are alleviated whilst engaged in a binge [39]. Longitudinal studies using Ecological 
Momentary Assessment technology also report that binge eating and subsequent purging are 
usually preceded by dysphoric mood states [50-52]. However, there is high prevalence of 
depression and emotion dysregulation in BN populations [53], so it is not clear whether such 
presentations of low mood represent psychological withdrawal from food. Future research 
should aim to elucidate whether dysphoric mood states before bingeing are distinct from more 
permanent mood-related comorbidities, perhaps by comparing depressed versus non-depressed 
individuals with BN.  
The first and only tool to evaluate withdrawal in the context of addictive-like eating has 
been developed recently: The Highly Processed Food Withdrawal Scale – ProWS [39]. This in 
part is derived from the premise that specific nutritional ingredients are capable of triggering 
addictive-like responses [54]. In a pilot study, the ProWS was found to be positively associated 
with elevated YFAS symptoms, BMI and weight cycling, in a community sample, and 
responses on the ProWS explained an additional 11.2% of the variance in self-reported dieting 
success [39]. This tool may help differentiate between the withdrawal effects from different 
types of palatable food  [55, 56] . 
 
The Impact of Glucose Metabolism on Hedonic Eating Behaviour 
Preclinical Evidence             
8 
 
Sweet, palatable foods act as an unconditioned rewarding stimulus in humans and 
rodent models, with evidence suggesting that merely tasting sucrose without digestion 
produces activation of dopaminergic circuits within the striatum [57]. However, there is 
evidence to suggest that palatable foods with a high glycaemic index further contribute to the 
development of compulsive binge eating behaviour through changes in dopaminergic 
functioning triggered by wide swings in blood glucose. One candidate mechanism for this 
effect relates to the interaction between insulin and dopaminergic functioning. 
The role of mesolimbic dopaminergic functioning in food approach behaviours has 
been reviewed extensively elsewhere [58]. Dopamine-deficient mouse models exhibit severe 
aphagia leading to weight loss and death [59]. Conversely the stimulation of dopaminergic 
activity within the striatum triggers food consumption in rats without enhancing “liking” 
responses (e.g., lip-licking and paw licking). Thus, dopaminergic functioning is thought to hold 
a role  in food approach behaviours (wanting) that is discrete from the hedonic response to food 
receipt [60]. In contrast, central insulin suppresses feeding [61]. It is thought that the effects of 
central insulin and dopamine on food intake, are not independent, but rather interact to regulate 
hedonic eating behaviour. 
Dopaminergic neurons within the ventral tegmental area (VTA) express insulin 
receptors [62, 63], presenting a possible mechanism by which insulin might influence the 
dopaminergic induction of feeding behaviour. Furthermore, central insulin enhances the 
expression of dopamine transporter protein within the VTA via a protein kinase B (Akt) 
signalling system [64, 65]. The enhanced expression of dopamine transporters on the cell 
surface induced by insulin exposure is associated with greater dopamine uptake [66], thus 
reducing levels of synaptic dopamine. 
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            With regards to the effects of insulin on postsynaptic dopaminergic signalling, in vitro 
studies have found that insulin exposure invokes long-term depression of excitatory signalling 
within VTA dopamine neurons extracted from male C57BL/6J mice [67]. This effect appears 
to be long-lasting as, once induced, the long-term depression of VTA dopamine cells is not 
reversed by application of the insulin receptor antagonist S961 or through a tyrosine kinase 
inhibitor, which suppresses insulin receptor functioning [67]. 
            The effects of central insulin on dopaminergic functioning within the VTA likely have 
downstream effects in suppressing feeding, and particularly hedonic feeding. For example, 
Bruijnzeel, et al. [68] found that injecting insulin directly into the VTA of female rats decreased 
24-hour food intake. Mebel, et al. [69] have similarly found that injecting insulin directly into 
the VTA suppresses subsequent feeding in male C57BL/6J mice; however, this effect was 
dependent on the hunger status of the animals. That is, insulin in the VTA suppressed the 
quantity of sweetened high fat food consumed by sated mice but did not affect normal chow 
intake in hungry mice. This pattern of effects therefore suggests that insulin activity in the VTA 
acts selectively to suppress subsequent hedonic feeding, with weaker evidence for effects on 
homeostatic feeding behaviour.  
            Central insulin functioning may play a role in blocking the memory of palatable food 
reward or attenuating the incentive salience of cues associated with palatable food. Evidence 
for this hypothesis comes from studies demonstrating that injecting insulin either into the 
cerebral ventricles [70] or VTA [67] of rats at the time of memory retrieval reduces conditioned 
place preference for palatable food. Furthermore, Bruijnzeel, et al. [68] found that injecting 
insulin at a dose of .005mU/side into the VTA elevated the reward threshold for intracranial 
self-stimulation, thus indicating a reduction of reward functioning.  
 Evidence in Humans 
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Insulin resistance impacts on central dopaminergic systems in humans. For example, 
Dunn, et al. [71] conducted a positron emission tomography (PET) study using the dopamine 
D2/D3 receptor radioligand [18F]fallypride, and found that insulin sensitivity is negatively 
correlated with dopamine type 2 receptor availability in the ventral striatum in a heterogeneous 
sample of lean and obese women. In men, Anthony, et al. [72] found that exogenously 
administered insulin increases metabolism in the ventral striatum and prefrontal cortex, while 
decreasing metabolism in the right amygdala, hippocampus, and cerebellar vermis. 
Furthermore, the effect of insulin in increasing metabolism in the ventral striatum and PFC was 
lower in insulin-resistant, versus insulin-sensitive participants [72]. This pattern of findings is 
thus indicative of trait-level differences in the effects of central insulin on dopaminergic 
mesolimbic regions, known to be critical for food craving and food approach behaviour [59, 
73]. 
 Interactions between insulin resistance and central dopaminergic functioning may have 
functional significance for food craving in humans. Chechlacz, et al. [74], in an fMRI study, 
found that people with Type II diabetes mellitus (characterised by insulin resistance) exhibit 
greater blood oxygenated level dependent (BOLD) response to food versus non-food images 
in the insula, orbitofrontal cortex (OFC), and basal ganglia, when compared to people without 
diabetes mellitus. Moreover, this increased activation within the insula and OFC is positively 
correlated with self-reported external eating. These findings, taken together, thus provide 
evidence that insulin resistance, commonly observed following repeated excess consumption 
of fructose in combination with an overall excessive energy intake [75], is positively correlated 
with a pattern of neural response to food stimuli which is associated with greater external cue-
driven eating. However, it should be noted that the correlational nature of these findings limits 
the ability to draw firm causal inferences. Although there is relatively less evidence regarding 
food craving in Type I diabetes, an fMRI study has found that insulin detemir, which more 
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readily enters the brain compared to standard forms of insulin, is associated with reduced 
BOLD response to food images in the bilateral insula, a brain region associated with the 
regulation of appetite [76]. The authors have speculated that insulin detemir may therefore 
induce a more effective satiety reaction, thus explaining the reduced levels of weight gain 
observed in people with Type I diabetes mellitus taking insulin detemir [77]. 
 In a related study, Jastreboff, et al. [78] recruited 25 men and women in the obese 
weight range and 25 lean controls. Fasting insulin and glucose were taken to measure insulin 
resistance. During a subsequent fMRI task, audio scripts designed to provoke relaxing imagery 
or favourite food imagery were played. Food craving was assessed before and after each 
imagery trial. The degree of food craving following food imagery trials was positively 
associated with insulin resistance in the obese, but not lean, participant group. Furthermore, 
the relationship between insulin resistance and food craving within the obese participant group 
was mediated by BOLD responses in dopaminergic regions including the ventral tegmental 
area (VTA) and substantia nigra. These studies suggest that insulin resistance moderates 
craving and associated neural circuits in response to food related imagery.  
 Thus, the above studies illustrate that interactions between central insulin and 
dopaminergic systems, known to impact on feeding behaviour in animals, also regulate food 
craving in humans. While this evidence therefore supports a potential mechanism linking the 
short- and long-term physiological effects of sugar consumption to food craving in humans, it 
is also of interest to disentangle the effects of sweet taste on dopaminergic incentive 
sensitisation from the physiological effects of sugar in food approach behaviour in humans. In 
support of the physiological effects of glucose consumption on central dopaminergic 
functioning, regardless of sweet taste. Haltia, et al. [79] found that the intravenous 
administration of glucose, versus placebo, was associated with increased D2 receptor binding 
potential in the right caudate nucleus and bilateral putamen in both lean and overweight 
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women. However, intravenous glucose administration was rather associated with reductions in 
D2 receptor binding potential in the bilateral caudate nucleus, left putamen, and right thalamus. 
It should be noted that the intravenous method of administration employed in this study 
bypassed the gastrointestinal system, thus failing to stimulate the production of gastrointestinal 
hormones, such as glucagon-like peptide 1, which also impact on appetitive functioning [80, 
81]. This study is therefore limited in the extent to which it directly bears upon the oral 
consumption of glucose versus calorie-free sweet taste. Nonetheless, these findings provide 
evidence for the impact of glucose on mesolimbic dopaminergic functioning in the absence of 
sweet taste. The functional significance of the sexual dimorphism in brain response is not yet 
clear and would be an interesting avenue for future research. 
In another PET study conducted in nineteen participants with BMIs ranging from the 
lean to obese weight range dopamine functioning was measured following the consumption of 
a 75g oral glucose drink versus a calorie-free sucralose drink of equal volume and sweetness. 
Within the lean participant group, consuming the glucose drink, versus the calorie-free 
sucralose drink, was associated with increased dopaminergic binding potential within the 
ventral striatum, while the opposite was observed in the obese participant group (Wang, et al. 
[82]. Thus, there is evidence that glucose impacts upon dopaminergic functioning separately 
from the effects of sweet taste alone, with BMI modulating the direction of that effect. The 
reduced activation stimulated by sugar consumption in obese participants is in line with 
previous evidence of down-regulated striatal response to the receipt of sugar solutions, 
including chocolate milk and milkshakes [83, 84]. 
There is a relative paucity of research investigating the effects of glucose metabolism 
on dopamine-mediated feeding in BN and binge eating disorder without obesity. A recent meta-
analysis of studies analysing insulin sensitivity in BN and binge eating disorders has found 
significantly reduced insulin sensitivity in both disorders [85]. Such insulin resistance therefore 
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leads to greater flux in blood glucose following the consumption of foods with a high glycaemic 
index, thus potentially contributing to food craving in a similar manner to that described above 
for populations with obesity [78]. The effect of insulin resistance on glucose flux is further 
exacerbated by the wide swings in blood glucose induced by intermittent fasting followed by 
objectively large binge eating episodes in people with BN [86]. Frank, et al. [87] found 
evidence of some trait differences in brain response to glucose, with participants recovered 
from BN exhibiting suppressed BOLD response to a glucose, versus artificial saliva solution, 
in the anterior cingulate cortex and left cuneus in comparison to the control group. However, 
this study is confounded by the difference in sweet taste as well as nutritional content (glucose 
versus calorie-free liquid). It will therefore be critical to carry out similar research to that 
described above for obesity in populations with bulimia-spectrum disorders in order to clarify 
the functional role of a glucose metabolism pathway in loss-of-control binge eating versus the 
chronic overeating which commonly characterises overweight and obesity.  
Conclusion 
The current literature review has thus far served to illustrate the existing state of the 
evidence with regards to food tolerance and withdrawal effects in BN. Additionally, preclinical 
and preliminary evidence in human studies has elucidated an insulin-dependent mechanism 
whereby foods with a high glycaemic index interact with mesolimbic dopamine systems and 
heighten food craving in cases of insulin dysregulation. Nonetheless, there are several lines of 
evidence that should be explored further before definite conclusions can be drawn with regards 
to withdrawal and tolerance in BN and the physiological mechanisms which maintain addictive 
responses to palatable food.  
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Table 1. DSM-5 criteria for an addictive disorder (American Psychiatric Association, 2013) 
 
Criteria 1. The substance is often taken in larger amounts or over a longer period than 
was intended  
Criteria 2. There is a persistent desire or unsuccessful efforts to cut down or control use 
of the substance 
Criteria 3. A great deal of time is spent in activities necessary to obtain the substance, use 
the substance, or recover from its effects 
Criteria 4. Craving, or a strong desire or urge to use the substance 
Criteria 5. Recurrent use of the substance despite having persistent or recurrent social or 
interpersonal problems caused or exacerbated by the effects of its use 
Criteria 6. Continued use of the substance despite having persistent or recurrent social or 
interpersonal problems caused or exacerbated by the effects of its use 
Criteria 7. Important social, occupational, or recreational activities are given up or 
reduced because of use of the substance 
Criteria 8. Recurrent use of the substance in situations in which it is physically hazardous 
Criteria 
9. 
Tolerance, as defined by either of the following:  
 
(a) A need for markedly increased amounts of the substance to achieve 
intoxication or desired effect  
(b) A markedly diminished effect with continued use of the same amount 
of the substance  
Criteria 
10. 
Withdrawal, as manifested by either of the following: 
 
(a) The characteristic withdrawal syndrome for other substance 
(b) The substance (or a closely related substance) is taken to relieve or 
avoid withdrawal symptoms  
 
 
